-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
InMed Pharmaceuticals Inc. quarterly/annual Depreciation history and growth rate from 2023 to 2024.
- InMed Pharmaceuticals Inc. Depreciation for the quarter ending September 30, 2024 was $13.6K, a 1.83% decline year-over-year.
- InMed Pharmaceuticals Inc. annual Depreciation for 2024 was $47.7K, a 20.5% increase from 2023.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)